SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-173000
Filing Date
2022-06-13
Accepted
2022-06-13 17:01:00
Documents
12
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d365326d8k.htm   iXBRL 8-K 35471
  Complete submission text file 0001193125-22-173000.txt   154472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA itci-20220609.xsd EX-101.SCH 2903
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20220609_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20220609_pre.xml EX-101.PRE 10844
6 EXTRACTED XBRL INSTANCE DOCUMENT d365326d8k_htm.xml XML 3208
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 221012381
SIC: 2834 Pharmaceutical Preparations